| Belle Chasse Optical | |
|
102 Woodland Hwy, Ste 10, Belle Chasse, LA 70037-1674 | |
| (504) 393-0002 | |
| (504) 392-0770 |
| Full Name | Belle Chasse Optical |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 102 Woodland Hwy, Belle Chasse, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568743771 | NPI | - | NPPES |
| 1175340 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1545-575T (Louisiana) | Primary |
| Provider Name | Thuy T Nguyen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1942490305 PECOS PAC ID: 4880731082 Enrollment ID: I20091020000718 |
News Archive
Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.
The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.
A team of researchers are to examine whether learning about injury prevention in school really can help to prevent a distressing trip to the A&E department for children and their parents.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
Investigators at St. Jude Children's Research Hospital have discovered how a single molecular "on switch" triggers gene activity that might cause effects ranging from learning and memory capabilities to glucose production in the liver.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Belle Chasse Optical 102 Woodland Hwy, Ste 10, Belle Chasse, LA 70037-1674 Ph: (504) 393-0002 | Belle Chasse Optical 102 Woodland Hwy, Ste 10, Belle Chasse, LA 70037-1674 Ph: (504) 393-0002 |
News Archive
Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.
The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.
A team of researchers are to examine whether learning about injury prevention in school really can help to prevent a distressing trip to the A&E department for children and their parents.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
Investigators at St. Jude Children's Research Hospital have discovered how a single molecular "on switch" triggers gene activity that might cause effects ranging from learning and memory capabilities to glucose production in the liver.
› Verified 9 days ago
Stephen M Welcker, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 400 Russell Ave Bldg 41, Belle Chasse, LA 70037 Phone: 504-678-7970 | |
Thuy Thanh Nguyen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 102 Woodland Hwy Ste 10, Belle Chasse, LA 70037 Phone: 504-393-0002 Fax: 504-392-0770 |